Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAtlantis, E.-
dc.contributor.authorFahey, P.-
dc.contributor.authorMartin, S.-
dc.contributor.authorO Loughlin, P.-
dc.contributor.authorTaylor, A.W.-
dc.contributor.authorAdams, R.J.-
dc.contributor.authorShi, Z.-
dc.contributor.authorWittert, G.-
dc.identifier.citationBMC Endocrine Disorders, 2016; 16(26):1-10-
dc.description.abstract<h4>Background</h4>Effective prevention of type 2 diabetes (T2D) requires early identification of high-risk individuals who might benefit from intervention. We sought to determine whether low serum testosterone, a novel risk factor for T2D in men, adds clinically meaningful information beyond current T2D risk models.<h4>Methods</h4>The Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) study population consists of 2563 community-dwelling men aged 35-80 years in Adelaide, Australia. Of the MAILES participants, 2038 (80.0 %) provided information at baseline (2002-2006) and follow-up (2007-2010). After excluding participants with diabetes (n = 317), underweight (n = 5), and unknown BMI status (n = 11) at baseline; and unknown diabetes status (n = 50) at follow-up; 1655 participants were followed for 5 years. T2D at baseline and follow-up was defined by self-reported diabetes, or fasting plasma glucose (FPG) ≥7.0 mmol/L (126.1 mg/dL), or glycated haemoglobin (HbA1c) ≥6.5 %, or diabetes medications. Risk models were tested using logistic regression models. Sensitivity, specificity, positive predictive values (PPV) were used to identify the optimal cut-off point for low serum testosterone for incident T2D and the area under the receiver operating characteristic (AROC) curve was used to summarise the predictive power of the model. 15.5 % of men had at least one missing predictor variable; addressed through multiple imputation.<h4>Results</h4>The incidence rate of T2D was 8.9 % (147/1655) over a median follow-up of 4.95 years (interquartile range: 4.35-5.00). Serum testosterone level predicted incident T2D (relative risk 0.96 [95 % CI: 0.92,1.00], P = 0.032) independent of current risk models including the AUSDRISK, but did not improve corresponding AROC statistics. A cut-off point of <16 nmol/L for low serum testosterone, which classified about 43 % of men, returned equal sensitivity (61.3 % [95 % CI: 52.6,69.4]) and specificity (58.3 % [95 % CI: 55.6,60.9) for predicting T2D risk, with a PPV of 12.9 % (95 % CI: 10.4,15.8).<h4>Conclusions</h4>Low serum testosterone predicts an increased risk of developing T2D in men over 5 years independent of current T2D risk models applicable for use in routine clinical practice. Screening for low serum testosterone in addition to risk factors from current T2D risk assessment models or tools, including the AUSDRISK, would identify a large subgroup of distinct men who might benefit from targeted preventive interventions.-
dc.publisherSpringer Nature-
dc.subjectDiabetes Mellitus, Type 2-
dc.subjectBlood Glucose-
dc.subjectEarly Diagnosis-
dc.subjectRisk Assessment-
dc.subjectRisk Factors-
dc.subjectSensitivity and Specificity-
dc.subjectCohort Studies-
dc.subjectPredictive Value of Tests-
dc.subjectROC Curve-
dc.subjectAged, 80 and over-
dc.subjectMiddle Aged-
dc.titlePredictive value of serum testosterone for type 2 diabetes risk assessment in men-
dc.typeJournal article-
dc.identifier.orcidAtlantis, E. [0000-0001-5877-6141]-
dc.identifier.orcidTaylor, A.W. [0000-0002-4422-7974]-
dc.identifier.orcidShi, Z. [0000-0002-3099-3299]-
dc.identifier.orcidWittert, G. [0000-0001-6818-6065]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_100164.pdfPublished Version525.53 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.